dolasetron has been researched along with mdl 100907 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Galvan, M; Piguet, P | 1 |
| Carr, AA; Dudley, MW; Gittos, MW; Kehne, JH; Moser, P; Palfreyman, MG; Schmidt, CJ; Sorensen, SM | 1 |
2 other study(ies) available for dolasetron and mdl 100907
| Article | Year |
|---|---|
Transient and long-lasting actions of 5-HT on rat dentate gyrus neurones in vitro.
Topics: Animals; Bicuculline; Dioxins; Electrophysiology; Excitatory Amino Acid Antagonists; Fluorobenzenes; GABA Antagonists; Glutamic Acid; Hippocampus; Indoles; Long-Term Potentiation; Male; Piperidines; Quinolizines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Spiro Compounds; Tetrodotoxin | 1994 |
Electrophysiological, biochemical and behavioral evidence for 5-HT2 and 5-HT3 mediated control of dopaminergic function.
Topics: Animals; Basal Ganglia Diseases; Behavior, Animal; Dopamine; Electrophysiology; Fluorobenzenes; Indoles; Male; Mice; Microdialysis; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Piperidines; Quinolizines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin Antagonists | 1993 |